Literature DB >> 27581128

A collaborative approach to cancer risk assessment services using genetic counselor extenders in a multi-system community hospital.

Stephanie A Cohen1, Dawn M Nixon2.   

Abstract

PURPOSE: This study aimed to evaluate a unique approach to cancer risk assessment for improved access by smaller rural communities.
METHODS: Local, on-site nurse navigators were trained and utilized as genetic counselor extenders (GCEs) to provide basic risk assessment and offer BRCA1/2 genetic testing to select patients based on a triaging process in collaboration with board-certified genetic counselors (CGCs).
RESULTS: From August 2012 to July 2014, 12,477 family history questionnaires representing 8937 unique patients presenting for a screening mammogram or new oncology appointment were triaged. Of these, 8.2 % patients were identified at increased risk for hereditary breast cancer, and 4.2 % were identified at increased risk for other hereditary causes of cancer. A total of 75 of 1130 at-risk patients identified (6.6 %) completed a genetic risk assessment appointment; 23 with a GCE and 52 with a CGC. A review of the completed genetic test requisition forms from a 9-year pre-collaboration time period found that 16 % (20/125) did not appear to meet genetic testing criteria. Overall, there was a fourfold increase in patients accessing genetic services in this study period compared to the pre-collaboration time period. Efficiency of this model was assessed by determining time spent by the CGC in all activities related to the collaboration, which amounted to approximately 16 h/month. Adjustments have been made and the program continues to be monitored for opportunities to improve efficiency.
CONCLUSION: This study demonstrates the feasibility of CGCs and GCEs collaborating to improve access to quality services in an efficient manner.

Entities:  

Keywords:  Access; Genetic counseling; Genetic counselor extenders; Hereditary cancer risk assessment

Mesh:

Year:  2016        PMID: 27581128     DOI: 10.1007/s10549-016-3964-z

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  7 in total

1.  Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines.

Authors:  Piper Nicolosi; Elisa Ledet; Shan Yang; Scott Michalski; Brandy Freschi; Erin O'Leary; Edward D Esplin; Robert L Nussbaum; Oliver Sartor
Journal:  JAMA Oncol       Date:  2019-04-01       Impact factor: 31.777

Review 2.  The composition and capacity of the clinical genetics workforce in high-income countries: a scoping review.

Authors:  Nick Dragojlovic; Kennedy Borle; Nicola Kopac; Ursula Ellis; Patricia Birch; Shelin Adam; Jan M Friedman; Amy Nisselle; Alison M Elliott; Larry D Lynd
Journal:  Genet Med       Date:  2020-06-24       Impact factor: 8.822

3.  Use of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countries.

Authors:  Anne Brédart; Jean-Luc Kop; Antonis C Antoniou; Alex P Cunningham; Antoine De Pauw; Marc Tischkowitz; Hans Ehrencrona; Sylvie Dolbeault; Léonore Robieux; Kerstin Rhiem; Douglas F Easton; Peter Devilee; Dominique Stoppa-Lyonnet; Rita Schmutlzer
Journal:  Fam Cancer       Date:  2018-01       Impact factor: 2.375

4.  Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?

Authors:  Peter D Beitsch; Pat W Whitworth; Kevin Hughes; Rakesh Patel; Barry Rosen; Gia Compagnoni; Paul Baron; Rache Simmons; Linda Ann Smith; Ian Grady; Michael Kinney; Cynara Coomer; Karen Barbosa; Dennis R Holmes; Eric Brown; Linsey Gold; Patricia Clark; Lee Riley; Samuel Lyons; Antonio Ruiz; Sadia Kahn; Heather MacDonald; Lisa Curcio; Mary Kay Hardwick; Shan Yang; Ed D Esplin; Robert L Nussbaum
Journal:  J Clin Oncol       Date:  2018-12-07       Impact factor: 44.544

Review 5.  The Feasibility of Implementing Mainstream Germline Genetic Testing in Routine Cancer Care-A Systematic Review.

Authors:  Kyra Bokkers; Michiel Vlaming; Ellen G Engelhardt; Ronald P Zweemer; Inge M van Oort; Lambertus A L M Kiemeney; Eveline M A Bleiker; Margreet G E M Ausems
Journal:  Cancers (Basel)       Date:  2022-02-19       Impact factor: 6.639

Review 6.  Evaluating the role of public health in implementation of genomics-related recommendations: a case study of hereditary cancers using the CDC Science Impact Framework.

Authors:  Ridgely Fisk Green; Mary Ari; Katherine Kolor; W David Dotson; Scott Bowen; Nancy Habarta; Juan L Rodriguez; Lisa C Richardson; Muin J Khoury
Journal:  Genet Med       Date:  2018-06-15       Impact factor: 8.822

7.  Maximizing cancer prevention through genetic navigation for Lynch syndrome detection in women with newly diagnosed endometrial and nonserous/nonmucinous epithelial ovarian cancer.

Authors:  Soyoun Rachel Kim; Alicia Tone; Raymond H Kim; Matthew Cesari; Blaise A Clarke; Lua Eiriksson; Tae L Hart; Melyssa Aronson; Spring Holter; Alice Lytwyn; Manjula Maganti; Leslie Oldfield; Steven Gallinger; Marcus Q Bernardini; Amit M Oza; Bojana Djordjevic; Jordan Lerner-Ellis; Emily Van de Laar; Danielle Vicus; Trevor J Pugh; Aaron Pollett; Sarah E Ferguson
Journal:  Cancer       Date:  2021-05-13       Impact factor: 6.860

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.